Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Baxter International Yönetim
Yönetim kriter kontrolleri 3/4
Baxter International's CEO'su Joe Almeida, Jan2016 tarihinde atandı, in görev süresi 8.75 yıldır. in toplam yıllık tazminatı $ 13.79M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.4% maaş ve 90.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.11% ine doğrudan sahiptir ve bu hisseler $ 21.64M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2 yıl ve 4.7 yıldır.
Anahtar bilgiler
Joe Almeida
İcra Kurulu Başkanı
US$13.8m
Toplam tazminat
| CEO maaş yüzdesi | 9.4% |
| CEO görev süresi | 8.8yrs |
| CEO sahipliği | 0.1% |
| Yönetim ortalama görev süresi | 2yrs |
| Yönetim Kurulu ortalama görev süresi | 4.7yrs |
Son yönetim güncellemeleri
Recent updates
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?
Sep 05
Baxter- Reiterating Our Buy Rating After A Promising Q2
Aug 07Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29
Aug 07Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
Jul 23Baxter: Why Investors Should Take Advantage Of The Low Valuation
Jul 16Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues
Jul 12Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 30Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
May 14Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
May 08Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 20Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden
Jan 28Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital
Jan 12Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares
Dec 28Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Dec 12Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)
Nov 27Is Baxter International (NYSE:BAX) A Risky Investment?
Oct 27Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
Oct 12There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital
Sep 21Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Aug 23Dividend Challengers Review: Baxter International
Aug 14Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Jul 25Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet
Jul 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture
Jun 07Baxter International's (NYSE:BAX) Dividend Will Be $0.29
May 19Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 05Baxter International Inc.'s (NYSE:BAX) Intrinsic Value Is Potentially 26% Above Its Share Price
Apr 24CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$157m |
| Mar 31 2024 | n/a | n/a | -US$38m |
| Dec 31 2023 | US$14m | US$1m | -US$76m |
| Sep 30 2023 | n/a | n/a | US$225m |
| Jun 30 2023 | n/a | n/a | -US$3b |
| Mar 31 2023 | n/a | n/a | -US$3b |
| Dec 31 2022 | US$14m | US$1m | -US$3b |
| Sep 30 2022 | n/a | n/a | -US$3b |
| Jun 30 2022 | n/a | n/a | US$876m |
| Mar 31 2022 | n/a | n/a | US$992m |
| Dec 31 2021 | US$16m | US$1m | US$1b |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$1b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$16m | US$1m | US$1b |
| Sep 30 2020 | n/a | n/a | US$911m |
| Jun 30 2020 | n/a | n/a | US$924m |
| Mar 31 2020 | n/a | n/a | US$991m |
| Dec 31 2019 | US$14m | US$1m | US$1b |
| Sep 30 2019 | n/a | n/a | US$1b |
| Jun 30 2019 | n/a | n/a | US$1b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$16m | US$1m | US$2b |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$795m |
| Mar 31 2018 | n/a | n/a | US$840m |
| Dec 31 2017 | US$15m | US$1m | US$609m |
Tazminat ve Piyasa: Joe 'ın toplam tazminatı ($USD 13.79M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 13.04M ).
Tazminat ve Kazançlar: Joe şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Joe Almeida (62 yo)
8.8yrs
Görev süresi
US$13,786,671
Tazminat
Mr. Jose E. Almeida, also known as Joe, has been the Chairman of the Board and Chief Executive Officer of Baxter International Inc. since January 1, 2016 and serves as its President since January 01, 2016....
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board | 8.8yrs | US$13.79m | 0.11% $ 20.0m | |
| Executive VP | less than a year | US$5.37m | 0% $ 0 | |
| Executive VP & Group President of Medical Products and Therapies | 1.6yrs | US$4.86m | 0.031% $ 5.6m | |
| Executive VP & Group President of Pharmaceuticals | 2.3yrs | US$3.87m | 0.0024% $ 422.4k | |
| Executive VP & Group President of Kidney Care | 1.3yrs | US$9.64m | 0.0046% $ 817.9k | |
| Senior VP and Chief Medical & Scientific Officer | 1.8yrs | Veri yok | Veri yok | |
| Senior VP & Chief Information Officer | less than a year | Veri yok | Veri yok | |
| Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Executive VP & General Counsel | 2.5yrs | US$5.66m | 0.0018% $ 323.9k | |
| Senior Vice President | no data | Veri yok | Veri yok | |
| Executive VP & Chief Human Resources Officer | 7.4yrs | US$4.14m | 0.037% $ 6.6m | |
| Executive VP & Chief Supply Chain Officer | 4.8yrs | Veri yok | 0.0036% $ 644.3k |
2.0yrs
Ortalama Görev Süresi
54yo
Ortalama Yaş
Deneyimli Yönetim: BAX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board | 8.8yrs | US$13.79m | 0.11% $ 20.0m | |
| Independent Director | 1.2yrs | US$197.82k | 0.0018% $ 318.6k | |
| Chairman Emeritus | 8.8yrs | US$17.88m | Veri yok | |
| Independent Director | 2.4yrs | US$349.64k | 0.0026% $ 465.3k | |
| Independent Director | 7.7yrs | US$373.98k | 0.0055% $ 979.0k | |
| Independent Director | 5.7yrs | US$364.98k | 0.0042% $ 749.9k | |
| Independent Director | 2.8yrs | US$363.00k | 0.0028% $ 501.1k | |
| Independent Director | 7.8yrs | US$367.31k | 0.0044% $ 791.0k | |
| Lead Independent Director | 2.4yrs | US$382.31k | 0.0026% $ 465.3k | |
| Independent Director | 3.7yrs | US$357.00k | 0.0032% $ 570.9k | |
| Independent Director | 1.3yrs | US$226.35k | 0.0019% $ 345.4k | |
| Independent Director | 5.7yrs | US$352.98k | Veri yok |
4.7yrs
Ortalama Görev Süresi
66yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: BAX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.7 yıldır).